All questions
Safety: Vraylar (cariprazine) in major depressive disorder 10 questions · 3 sources
Safety questions that apply to every indication of Vraylar are on Vraylar (cariprazine), all indications: Safety .
Side effects What are the most common side effects of Vraylar for depression? “Adjunctive Treatment of Major Depressive Disorder:
In 6-week, fixed-dose trials the incidences within the recommended doses (VRAYLAR 1.5 mg/day + antidepressant therapy [ADT] or 3 mg/day + ADT vs placebo + ADT) were akathisia (7%, 10% vs 2%), nausea (7%, 6% vs 3%), and insomnia (9%, 10% vs 5%).
In one 8-week flexible-dose trial, incidences within the doses (VRAYLAR 1-2 mg/day + antidepressant therapy [ADT] or 2-4.5 mg/day + ADT vs placebo + ADT) were akathisia (8%, 23% vs 3%), restlessness (8%, 8% vs 3%), fatigue (7%, 10% vs 4%), constipation (2%, 5% vs 2%), nausea (7%, 13% vs 5%), increased appetite (2%, 5% vs 2%), dizziness (4%, 5% vs 2%), insomnia (14%, 16% vs 8%), and extrapyramidal symptoms (12%, 18% vs 5%).” (opens the source at this quote in a new tab) Copy Flag
Note: The 2-4.5 mg/day arm of the 8-week trial extends above the 3 mg/day maximum recommended dosage for MDD.
Does Vraylar cause weight gain when added to an antidepressant? Does Vraylar raise prolactin levels in depression trials? How common is akathisia with Vraylar for depression? Note: The percentages are for placebo + antidepressant, Vraylar 1.5 mg/day + antidepressant, and Vraylar 3 mg/day + antidepressant in two 6-week MDD studies, as in the table header on the safety page.
Does Vraylar cause drowsiness or sedation in depression trials? Does Vraylar cause sexual side effects in depression trials? How many patients stopped Vraylar because of side effects in depression trials? Safety management How was akathisia from Vraylar managed in the depression trials? Warnings Can Vraylar cause tardive dyskinesia? Note: The second figure (8 of 7,431 patients) counts 21 trials across all four Vraylar development programs, including bipolar I disorder and schizophrenia.